1997
DOI: 10.1146/annurev.med.48.1.93
|View full text |Cite
|
Sign up to set email alerts
|

Use of Intravenous Immunoglobulin to Prevent or Treat Infections in Persons With Immune Deficiency

Abstract: Intravenous immunoglobulin (IVIG) concentrates were originally developed as replacement therapy for individuals with primary deficiencies of the immune system. However, in various well-designed, controlled clinical trials, the ability of IVIG to prevent and possibly treat infections in patients with secondary immune deficiencies has also been considered. In this review, we briefly consider these different applications and suggest whether the data are sufficient to employ IVIG in these clinical settings.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1998
1998
2011
2011

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 41 publications
(1 citation statement)
references
References 79 publications
0
1
0
Order By: Relevance
“…Patients with multiple myeloma and chronic lymphoid leukemia, when they concomitantly have a low level of immunoglobulins and recurrent bacterial infections, are also candidates for Ig therapy. (5,6) …”
Section: Approved Indications For Immunoglobulinmentioning
confidence: 99%
“…Patients with multiple myeloma and chronic lymphoid leukemia, when they concomitantly have a low level of immunoglobulins and recurrent bacterial infections, are also candidates for Ig therapy. (5,6) …”
Section: Approved Indications For Immunoglobulinmentioning
confidence: 99%